Results
1 -
10 of
36The conscientious judgement of a DSMB u2013 statistical stopping rules re-examined, European Journal of Clinical Pharmacology Oral Agents, Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease Oral Platelet Glycoprotein IIb/IIIa Blockade, Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease Die Kardiologie auf dem Weg in das n??chste Jahrtausend, Der Internist Drug-induced thrombocytopenia and thrombosis: Evidence from patients receiving an oral glycoprotein IIb/IIIa inhibitor in the Orbofiban in Patients with Unstable coronary Syndromes- (OPUS-TIMI 16) trial, Journal of Thrombosis and Thrombolysis Antiplatelet Therapy in Acute Coronary Syndromes without Persistent ST-Segment Elevation, Cardiovascular Drugs and Therapy Aspirin Use Post-Acute Coronary Syndromes: Intolerance, Bleeding and Discontinuation, Journal of Thrombosis and Thrombolysis Oral platelet glycoprotein IIb/IIIa inhibition, Current Cardiology Reports Oral glycoprotein IIb/IIIa antagonists in coronary artery disease, Current Cardiology Reports Clinical trials report, Current Cardiology Reports